HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahasweta Gooptu Selected Research

Mahasweta Gooptu Research Topics

Disease

15Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 01/2017
7Neoplasms (Cancer)
06/2023 - 01/2017
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 11/2019
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2024 - 11/2019
4Bronchiolitis Obliterans Syndrome
01/2023 - 11/2018
4Infections
01/2022 - 01/2021
3Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2018
3Cytokine Release Syndrome
01/2023 - 01/2021
3Leukemia
12/2022 - 01/2020
2Hematuria
11/2022 - 12/2020
1Cytopenia
05/2024
1Opportunistic Infections (Opportunistic Infection)
11/2023
1Acute Kidney Injury (Acute Renal Failure)
01/2023
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2023
1Injection Site Reaction
12/2022
1Epistaxis (Nosebleed)
11/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2022
1Hypotension (Low Blood Pressure)
11/2022
1Viremia
01/2022
1COVID-19
01/2021
1Inflammation (Inflammations)
11/2020
1Dysbiosis
11/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Chromosome Aberrations (Chromosome Abnormalities)
01/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2019

Drug/Important Bio-Agent (IBA)

6Tacrolimus (Prograf)FDA LinkGeneric
01/2024 - 01/2017
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 01/2018
4Methotrexate (Mexate)FDA LinkGeneric
01/2024 - 11/2019
2venetoclaxIBA
01/2024 - 12/2021
2Azacitidine (5 Azacytidine)FDA Link
01/2024 - 12/2022
2SteroidsIBA
01/2023 - 12/2021
2Natalizumab (Tysabri)FDA Link
05/2021 - 01/2021
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021 - 01/2021
2AntigensIBA
11/2020 - 01/2018
1Prostaglandins FIBA
05/2024
1fludarabineIBA
02/2024
1Busulfan (Busulfex)FDA Link
02/2024
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2023
1Calcineurin InhibitorsIBA
06/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Abatacept (Orencia)FDA Link
01/2023
1Alemtuzumab (Campath)FDA Link
01/2023
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2022
1VaccinesIBA
12/2022
1eprenetapoptIBA
12/2022
1CytokinesIBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1ibrutinibIBA
12/2021
1letermovirIBA
08/2021
1ProgesteroneFDA LinkGeneric
01/2021
1InterferonsIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1trans-crotonin (CTN)IBA
11/2019
1Sirolimus (Rapamycin)FDA Link
11/2019
1Thomsen-Friedenreich antibodiesIBA
11/2018
1GlobulinsIBA
11/2018
1Lactic Acid (Lactate)FDA LinkGeneric
01/2017

Therapy/Procedure

9Therapeutics
01/2024 - 11/2019
8Cell Transplantation
05/2024 - 11/2019
7Hematopoietic Stem Cell Transplantation
01/2024 - 01/2021
4Transplantation
11/2023 - 01/2021
2Homologous Transplantation
01/2023 - 01/2021
1Stem Cell Transplantation
02/2024
1Immunotherapy
01/2022
1Length of Stay
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Donor Selection
01/2021
1Drug Therapy (Chemotherapy)
01/2018
1Chemoradiotherapy
01/2018